Here, the observed downregulation in both mRNA and protein levels of Cyclin A2 and Cyclin B2 upon silencing or knocking out ORC6, as well as the increased cyclins expression upon ORC6 overexpression in primary human glioma cells (Fig. 9I). The gene discussed is ORC6; the disease is central nervous system cancer.